Our integrated and personalized approach

At neuroCare, we offer sustainable outcomes in therapy for mental disorders, chronic pain and for rehabilitation. The individualised therapy concepts offered at neuroCare clinics are achieved by integrating the expertise of mental health therapists with leading neuromodulation technology. At neuroCademy we educate clinicians and researchers in the area of neuromodulation technologies and how to apply them in daily clinical practice. Development in research and patient care is anchored by the neuroConn technology brand, a global leader and industry pioneer in non-invasive neuromodulation technology​​​​​.

Everything we do, think or feel is a memorized pattern in our brain or muscle memory. Neuromodulation helps to reprogram those patterns by training our mind to more positive behaviour or for better cognitive performance. Behavourial, cognitive or motor disturbances can be treated faster and more efficiently when neurotechnology and the therapist work in synergy. Our integrated approach (i.e. cognitive therapy combined with individualised neurotherapy) shows an efficacy of 75 % for patients with ADHD and an efficacy of 78 % for patients with depression. This is a fact we are truly proud of.

At neuroCare, we also apply neurotechnologies in the diagnosis of mental disorders allowing the therapist to personalize the treatment to the patient’s individual need - this is called prognostics.​​ Most current treatments in mental health or neurology, particularly psychopharmaceuticals, still rely on a one-size-fits-all approach. Individual differences are ignored even though not all patients have the same underlying cause for their symptoms. Our integrated and personalized approach to therapy is needed​.​ neuroCare is a leader in the fast growing neurotherapy market.​

More about the neuroCare Group


MJA report shows need for alternatives to anti-depressants

Authors Christopher Davey and Andrew Chanen call for alternatives to anti-depressant medication to improve outcomes for patients suffering depression. They highlight in their article that while anti-depressants still have an important role in patient treatment, medication is more effective if given in combination with other therapies. You can read the full article here.

More News

Introduction to the neuroCare Group